Onco-Innovations Limited (CVE:ONCO) | WebDisclosure

Basculer en Français

11336	Companies
251966	Keywords
181326	Articles
137788	Press releases

Headlines Articles Press releases Onco-Innovations Limited

Home
Companies
Onco-Innovations Limited

PRESS RELEASE

published on 04/11/2025 at 00:00, 1 year 7 months ago

Onco-Innovations’ Inka Health Publishes Roche-Sponsored Study Advancing Real-World Oncology Research
Onco-Innovations Limited announces groundbreaking study on adjusting bias in real-world oncology research, published in JAMA Network Open, offering a method to enhance clinical comparisons

Bias Analysis Onco-Innovations Limited Real-world Oncology Research JAMA Network Open Clinical Comparisons
BRIEF

published on 04/04/2025 at 00:05, 1 year 7 months ago

Inka Health's Analytical Achievements for AstraZeneca Canada Highlighted at ISPOR 2025

Real-world Evidence Pharmaceutical Analytics ISPOR 2025 Healthcare Decision-Making AstraZeneca Collaboration
BRIEF

published on 04/04/2025 at 00:05, 1 year 7 months ago

Les réalisations analytiques d'Inka Health pour AstraZeneca Canada mises en lumière à l'ISPOR 2025

Preuves Du Monde Réel ISPOR 2025 Analyse Pharmaceutique Prise De Décision En Matière De Soins De Santé Collaboration Avec AstraZeneca
PRESS RELEASE

published on 04/04/2025 at 00:00, 1 year 7 months ago

Onco-Innovations' Inka Health Completes Analytical Work for AstraZeneca Canada, Advancing Pharmaceutical Analytics and Leading to Key Studies at ISPOR 2025
Onco-Innovations Limited's subsidiary, Inka Health Corp., completes analytical work for AstraZeneca Canada, showcasing advancements in pharmaceutical evidence generation and real-world data use

Real-world Data Onco-Innovations Limited Inka Health Corp. AstraZeneca Canada Pharmaceutical Evidence Generation
BRIEF

published on 03/26/2025 at 23:05, 1 year 7 months ago

Study Explores Low Toxicity of Onco-Innovations' PNKP Technology

Cancer Treatment Radiation Therapy Onco-Innovations PNKP Technology Low Toxicity
BRIEF

published on 03/26/2025 at 23:05, 1 year 7 months ago

Une étude explore la faible toxicité de la technologie PNKP d'Onco-Innovations

Traitement Du Cancer Radiothérapie Onco-Innovations Technologie PNKP Faible Toxicité
PRESS RELEASE

published on 03/26/2025 at 23:00, 1 year 7 months ago

Onco-Innovations' PKNP Technology Used with Radiation Therapy Shown in Study to Demonstrate Low Toxicity and High Safety Profile
Onco-Innovations Limited announces successful nanoparticle formulation of PNKP Compound with low toxicity and effective cancer cell targeting in mice, promising safer treatment options

Cancer Treatment Onco-Innovations Limited Nanoparticle Formulation PNKP Compound Low Toxicity
BRIEF

published on 03/25/2025 at 22:05, 1 year 7 months ago

Onco-Innovations Extends Marketing Partnership with MCS

Digital Advertising Onco-Innovations Marketing Extension MCS Partnership CAD 600,000 Budget
BRIEF

published on 03/25/2025 at 22:05, 1 year 7 months ago

Onco-Innovations étend son partenariat marketing avec MCS

Publicité Numérique Onco-Innovations Extension Marketing Partenariat MCS Budget De 600 000 $ CA
PRESS RELEASE

published on 03/25/2025 at 22:00, 1 year 7 months ago

Onco-Innovations Extends Marketing Program
Onco-Innovations Limited extends engagement with MCS Market Communication Service GmbH for online marketing services until May 31, 2025. Company aims to revolutionize cancer treatment with patented technology

Patented Technology Cancer Treatment Onco-Innovations Limited MCS Market Communication Service GmbH Online Marketing Services

Accesswire

Published on 11/14/2026 at 12:56, 13 hours 24 minutes ago

Gabriel Announces Dismissal of ICSID Annulment Application
Published on 11/14/2026 at 01:30, 1 day ago

NuRAN Wireless Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency
Published on 11/14/2026 at 00:40, 1 day 1 hour ago

BEACN Announces Annual General and Special Meeting Results
Published on 11/14/2026 at 00:35, 1 day 1 hour ago

American Hotel Income Properties REIT LP Reports Q3 2026 Results
Published on 11/14/2026 at 00:00, 1 day 2 hours ago

SLAM Announces Proposed Extension of Warrant Expiry Dates

View all ACCESSWIRE

EQS Group

Published on 11/13/2026 at 23:24, 1 day 2 hours ago

EQS-Adhoc: ASOS PLC: Repurchase of £90m of 2028 Convertible Bonds
Published on 11/13/2026 at 21:52, 1 day 4 hours ago

EQS-Adhoc: Airbus reports share buyback transactions 9-13 November 2026
Published on 11/13/2026 at 19:15, 1 day 7 hours ago

Increase in Equity to Accelerate Growth
Published on 11/13/2026 at 19:08, 1 day 7 hours ago

EQS-Adhoc: CHAPTERS Group AG: Successful Completion of Private Placement of the Capital Increase from Authorized Capital Resolved on November 13, 2026
Published on 11/13/2026 at 19:00, 1 day 7 hours ago

Assemblée générale ordinaire des actionnaires le 18 décembre 2026

Les Echos

Published on 11/13/2026 at 17:45, 1 day 8 hours ago

STEF : Droits de vote au 31-10-2026
Published on 11/13/2026 at 11:35, 1 day 14 hours ago

ENGIE and Google to partner on energy solutions for a potential data center project near Châteauroux, France
Published on 11/13/2026 at 11:35, 1 day 14 hours ago

ENGIE et Google s’associent pour développer les solutions énergétiques d’un projet de data center envisagé près de Châteauroux, en France
Published on 11/13/2026 at 08:00, 1 day 18 hours ago

Résultats trimestriels au 30 septembre 2026 - ANR par action : 101,54 €, en progression de + 7,8 % sur 9 mois - Capitaux propres consolidés : 772 M€
Published on 11/12/2026 at 23:12, 2 days 3 hours ago

Belgrano continues the implementation of its public share buyback offer (OPRA)

View all LES ECHOS COMFI WIRE